Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Rani Therapeutics Holdings, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
4
| McKinley Kate (CHIEF BUSINESS OFFICER) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 250,000 options to buy
@ $4.13, valued at
$1M
|
|
| 05/30/2023 |
4
| IMRAN MIR A (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/30/2023 |
4
| Nanavaty Maulik (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/30/2023 |
4
| Rometty Lisa Ann (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/30/2023 |
4
| DEBUONO LAUREEN (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/30/2023 |
4
| BUTEL JEAN LUC (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/30/2023 |
4
| Ausiello Dennis A (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/30/2023 |
4
| Farquharson Andrew (Director) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Granted 101,276 options to buy
@ $4.11, valued at
$416.2k
|
|
| 05/10/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 4,420 shares
@ $4.4645, valued at
$19.7k
|
|
| 05/05/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 2,040 shares
@ $4.8118, valued at
$9.8k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 4,416 shares
@ $5.4906, valued at
$24.2k
Bought 7,280 shares
@ $5.487, valued at
$39.9k
|
|
| 04/05/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 3,587 shares
@ $5.2268, valued at
$18.7k
|
|
| 04/03/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 12,230 shares
@ $4.7901, valued at
$58.6k
Bought 751 shares
@ $5.0476, valued at
$3.8k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2023 |
4
| Sanford Svai S (CFO) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 3,355 shares
@ $5.95, valued at
$20k
|
|
| 03/24/2023 |
4
| Imran Talat (CEO) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 7,988 shares
@ $5.95, valued at
$47.5k
|
|
| 03/24/2023 |
4
| Groen Eric (General Counsel) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 2,498 shares
@ $5.95, valued at
$14.9k
|
|
| 03/24/2023 |
4
| Hashim Mir (Chief Scientific Officer) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 4,201 shares
@ $5.95, valued at
$25k
|
|
| 03/22/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 532 shares
@ $6.2926, valued at
$3.3k
Bought 3,230 shares
@ $6.0796, valued at
$19.6k
|
|
| 03/20/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 1,325 shares
@ $6.072, valued at
$8k
Bought 2,980 shares
@ $6.1906, valued at
$18.4k
|
|
| 03/15/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 2,463 shares
@ $6.1391, valued at
$15.1k
|
|
| 03/08/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 1,100 shares
@ $6.3927, valued at
$7k
|
|
| 03/06/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 3,900 shares
@ $6.31, valued at
$24.6k
|
|
| 03/02/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 711 shares
@ $6.2986, valued at
$4.5k
|
|
| 02/28/2023 |
4
| South Cone Investments Limited Partnership (10% Owner) has filed a Form 4 on Rani Therapeutics Holdings, Inc.|
Txns:
| Bought 5,451 shares
@ $6.0869, valued at
$33.2k
Bought 3,541 shares
@ $6.3, valued at
$22.3k
|
|
|
|
|